An interview with chief executive Perry Nisen of the nonprofit organization Sanford Burnham Prebys Medical Discovery Institute is presented. He addresses the role of big data in biomedicine and drug research. He discusses microbiome research decisions in the pharmaceutical industry. The role of basic research in the work of his institute is noted in relation to drug discovery research.